Mohs and Immunofluorescence for Malignant Melanoma In Situ (NCT02306512) | Clinical Trial Compass
WithdrawnNot Applicable
Mohs and Immunofluorescence for Malignant Melanoma In Situ
Stopped: PI is leaving the University of Miami
United States0Started 2015-06
Plain-language summary
The purpose of this study is to determine if immunofluorescence (IF) can effectively identify features of malignant melanoma in situ, on sun-damaged skin, in the setting of Mohs Micrographic Surgery.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Male or female of any race and at least 18 years of age
. Patient with biopsied proven Lentigo maligna (LM) in situ
. Patient meets criteria for Mohs Micrographic Surgery (MMS)
. The cancer is large
. The edges of the cancer (clinical margins) cannot be clearly defined
. Prior treatment has failed, i.e. recurrent tumor
. The cancer is located in a cosmetically sensitive or functionally critical area of the body (such as eyelids, nose, ears, lips, fingers, toes, and genitals)
. The histologic pattern of the cancer is aggressive
Exclusion criteria
. Patients under the age of 18
. Patient does not meet criteria for MMS or has LM located in areas that are not accessible with MMS
. Patient with previously diagnosed invasive LM
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
IF MART-1 versus Standard H&E and IHC MART-1
Timeframe: End of Mohs Surgery, approximately up to 24 hours